C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 417/14 (2006.01) A61K 31/427 (2006.01) A61P 3/04 (2006.01) A61P 25/20 (2006.01) C07D 403/14 (2006.01) C07D 413/12 (2006.01) C07D 413/14 (2006.01) C07D 417/06 (2006.01) C07D 473/36 (2006.01)
Patent
CA 2687230
The present invention is directed to cyclopropyl proline bis-amide compounds which are antagonists of orexin receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which orexin receptors are involved.
La présente invention concerne des composés de cyclopropylproline bis-amide qui sont des antagonistes des récepteurs de l'orexine et se révèlent utiles pour le traitement ou la prévention de troubles neurologiques et psychiatriques ainsi que de maladies impliquant les récepteurs de l'orexine. L'invention concerne également des compositions pharmaceutiques contenant lesdits composés et l'utilisation de ces composés et compositions pour la prévention ou le traitement desdites maladies impliquant les récepteurs de l'orexine.
Coleman Paul J.
Mercer Swati P.
Roecker Anthony J.
Merck & Co. Inc.
Merck Sharp & Dohme Corp.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Cyclopropyl pyrrolidine orexin receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclopropyl pyrrolidine orexin receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclopropyl pyrrolidine orexin receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1870222